Search for: "Par Pharmaceutical, Inc."
Results 101 - 120
of 171
Sorted by Relevance
|
Sort by Date
17 Jul 2018, 9:28 am
” Par Pharmaceutical, Inc. v. [read post]
5 Apr 2011, 2:35 pm
Par Pharmaceutical, Inc. [read post]
14 May 2019, 11:24 am
” PAR Pharm., Inc.v. [read post]
18 Aug 2010, 12:19 am
Par Pharmaceutical, Inc. et al. [read post]
5 May 2010, 4:46 am
Cyclacel Pharmaceuticals Inc. [read post]
15 Jun 2011, 4:56 am
Par Pharmaceutical, Inc. [read post]
10 Jun 2010, 3:58 am
Par Pharmaceutical, Inc. [read post]
25 Jun 2013, 9:51 am
Watson Pharmaceuticals, Inc. [5] Citing FTC v. [read post]
16 Nov 2011, 10:00 am
Reddy's Laboratories Ltd., and Par Pharmaceuticals Inc. [read post]
9 Mar 2009, 7:00 am
Skylight Studios275 Hudson Street, NYC7 pm - 10 pmPURCHASE TICKETS Participating chefs Anne BurrellThe Food Network Anita LoAnnisa Pichet OngP*ONG Suvir SaranDevi Lawrence Benenson Fiona and Stanley Druckenmiller Leslie Fay Pomerantz Anita Jaffe Bloomberg Davis Polk & Wardwell Jeffrey FashionCares 2009 May and Samuel Rudin Family Foundation Sonnenschein Nath &… [read post]
4 Jan 2022, 10:33 am
A Pennsylvania federal judge ordered California to pay nearly $80,000 in legal fees to Par Pharmaceutical Inc for failing to comply with discovery obligations in multidistrict litigation alleging a broad price-fixing conspiracy for generic drugs. [read post]
4 Jan 2022, 10:33 am
A Pennsylvania federal judge ordered California to pay nearly $80,000 in legal fees to Par Pharmaceutical Inc for failing to comply with discovery obligations in multidistrict litigation alleging a broad price-fixing conspiracy for generic drugs. [read post]
17 Oct 2010, 9:55 am
©2010 Amaxx Risk Solutions, Inc. [read post]
25 Jun 2013, 6:52 am
Soon after, two other companies, Actavis and Paddock (the latter in agreement with a third company, Par Pharmaceutical) had filed Abbreviated New Drug Applications for generic drugs modeled after AndroGel, declaring that Solvay’s patent 6,503,894 was invalid, under paragraph 4 of the Hatch-Waxman Act. [read post]
10 Oct 2013, 8:42 am
Par Pharmaceutical Companies Inc. ($45 million) Par Pharmaceutical Companies, Inc., one of the top five U.S. generic pharmaceutical companies, pleaded guilty to federal criminal charges and agreed to settle civil allegations involving the company’s promotion of the drug Megace ES. [read post]
28 Mar 2011, 2:42 pm
Karst – Late last week, Par Pharmaceutical, Inc. [read post]
21 Jan 2007, 8:53 pm
(a Par Pharmaceutical subsidiary), No. 02-CV-5707-JCL-MF (D. [read post]
3 Jun 2009, 5:49 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Singulair (Montelukast) – US: Merck & Co’s Singulair patent challenged on $50K bounty (Patent Baristas) (GenericsWeb) General Docs at BIO (Panel addresses narrowing scope of biotech patents – Patent Docs), (‘Perfect storm’ super session – Patent Docs) (Biotech… [read post]
3 Jun 2009, 5:49 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Singulair (Montelukast) – US: Merck & Co’s Singulair patent challenged on $50K bounty (Patent Baristas) (GenericsWeb) General Docs at BIO (Panel addresses narrowing scope of biotech patents – Patent Docs), (‘Perfect storm’ super session – Patent Docs) (Biotech… [read post]
25 Apr 2012, 1:56 pm
Watson Pharmaceuticals, Inc., No. 10-12729, is available here. [read post]
